Pathline's COVID-19 testing is now available. Learn More.

Test Directory

We offer a robust test menu to help providers diagnose and monitor a wide range of conditions. Our pathology capabilities include:

  • FISH (fluorescence in-situ hybridization)
  • Flow Cytometry
  • IHC (immunohistochemistry)
  • Cytogenetics
  • Molecular Diagnostics
  • Histology
  • Cytology
Name Methodology
MYD88 L265P mutation Molecular
Myelodysplasia Panel FISH
Myeloperoxidase Immunohistochemistry (IHC)
Myeloproliferative Disorders Panel FISH
Napsin A Immunohistochemistry (IHC)
Neurofilament Immunohistochemistry (IHC)
NextGen Sequencing Acute Myeloid Leukemia (AML) Panel (Major) Molecular
NextGen Sequencing GIST Panel Molecular
NextGen Sequencing HotSpot Cancer Panel Molecular
NextGen Sequencing Lung Panel (Major) Molecular
NextGen Sequencing Melanoma Panel Molecular
NextGen Sequencing Myelodysplastic Syndrome (MDS) Panel Molecular
NextGen Sequencing Myeloproliferative Neoplasm (MPN) Panel (Major) Molecular
NextGen Sequencing Prostate Panel Molecular
NextGen Sequencing Thyroid Panel Molecular
NKX3.1 Immunohistochemistry (IHC)
NPM1 Mutation Analysis Molecular
NSE Immunohistochemistry (IHC)
OCT-3/4 Immunohistochemistry (IHC)
OCT2 Immunohistochemistry (IHC)
p120 Immunohistochemistry (IHC)
p16 Immunohistochemistry (IHC)
p40 Immunohistochemistry (IHC)
p53 Immunohistochemistry (IHC)
P53 FISH